VALANX Biotech

📍 Klosterneuburg, Austria🗓 Founded 2017👥 15 employees💰 Last funded Jan 2022
Partner with us and leverage our technology for the development of the next wave of superior protein conjugates and Antibody-Drug-Conjugates! Looking to fast track your development of next generation bioconjugates, staying ahead of your competitors? With the complete freedom to choose where on the protein, we conjugate and optimize for: • Stability, • Aggregation, • Superior efficacy, • Therapeutic window ... and more! The process is simple! 1. Get in touch with us (message us here or visit our website). 2. After you let us know about your protein of interest, we produce different site-specific conjugate versions for you. 3. They are shipped either to you or your CRO. 4. You collect the data you need. 5. Go or no-go decision.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in VALANX Biotech?
VALANX Biotech has 1 investors on record on gritt.io, 1 mid-stage.
When did VALANX Biotech last raise funding?
The most recent investment in VALANX Biotech recorded on gritt.io was in January 2022.
When was VALANX Biotech founded?
VALANX Biotech was founded in 2017.
What industry is VALANX Biotech in?
VALANX Biotech operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is VALANX Biotech based?
VALANX Biotech is headquartered in Klosterneuburg, Austria.